Micheal Mutyaba Raymond
ID:
|
END OF PROGRAM EVALUATION FOR THE CITY WIDE INCLUSIVE SANITATION PROGRAM
REFNo: SS3202ES
a) Assess progress and Impact: the study aims at evaluating the progress made by the CWIS project in achieving its stated objectives and assess the impact of project interventions on targeted communities and institutions. This will involve examining whether the project has effectively increased access to improved onsite sanitation services, particularly for underserved urban poor households, public institutions, and transient populations; and
b) Provide recommendations for future Interventions: Based on the evaluation findings, formulate actionable recommendations for future sanitation interventions in Kampala and neighboring municipalities. These recommendations will aim at enhancing the effectiveness, efficiency, and sustainability of sanitation service delivery, contributing to the broader goal of urban transformation and improved public health outcomes.
|
Uganda |
2024-09-27 22:16:36 |
2027-09-27 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Vivian Najjuka NA
ID:
|
Health Information Seeking Behavior of People Living With Vitiligo in South Western Uganda
REFNo: SS3061ES
1. To establish the health information seeking practices for People Living with Vitiligo in South Western Uganda. 2. To determine the level of satisfaction with the health information sources by People Living with Vitiligo in South Western Uganda. 3. To identify the challenges encountered by People Living with Vitiligo in South Western Uganda, while seeking for health information on Vitiligo condition. 4. To explore interventions for enhancing health information access for coping with the Vitiligo condition in South Western Uganda.,The study seeks to explore the health information seeking behavior of People Living with Vitiligo in South Western Uganda and to propose interventions for enhancing HI access for coping with the Vitiligo condition.,
|
Uganda |
2024-09-27 22:09:53 |
2027-09-27 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Mikiko Nihimura
ID:
|
Exploring “Actionable Information” for Learning Improvement in Rural East Africa: A Positive Deviance Approach
REFNo: SS3226ES
To explore effective channels of information sharing towards improving education outcomes at child, household, and school levels.,To understand how parents and schools obtain and use information for pupils’learning at home and school,To understand how parents and schools obtain and use information for pupils’learning at home and schoolto explore effective channels of information sharing towards improving education outcomes at child, household, and school levels.,
|
Japan |
2024-09-27 22:07:58 |
2027-09-27 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
JAMES SSENFUUMA THOMAS
ID: UNCST-2023-R005484
|
2REST Responsibilities for Resilience Embedded in Street Temporalities: mapping street youth lived resiliences through analysis of secondary data
REFNo: SS3217ES
To analyse the GUOTS data set using a multisystemic resilience framework to street life experiences
To explore the data set longitudinally using a breadth and depth approach to understand temporal changes in young people’s lives, across diverse urban contexts, for creating interventions that develop as young people grow up
To explore with stakeholders, how the analysed evidence base can support young street people and inform policy and practice across diverse African and global contexts
|
Uganda |
2024-09-27 22:04:28 |
2027-09-27 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Bruce Kirenga J
ID: UNCST-2019-R001460
|
SMART (Smallpox vaccine for Mpox Post-Exposure Prophylaxis: A Cluster Randomized Controlled Trial)
REFNo: HS4726ES
Co-Primary objectives Co-primary: 1) To assess the effectiveness of the Smallpox vaccine in preventing RT-PCR confirmed Mpox infection among contacts of confirmed Mpox infection 2) To assess the effectiveness of the Smallpox vaccine in reducing the severity of symptoms; measured as symptom severity score, based on 12 symptom items (16) each assigned a score of 0 to 5 for a total measure of 0 to 60. These co-primary objectives will be evaluated during the first 28 days after randomization.
|
Uganda |
2024-09-27 14:06:23 |
2027-09-27 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
Joyce Nakatumba-Nabende
ID: UNCST-2020-R014244
|
Establishment of the Makerere University Centre for Artificial Intelligence and Data Science (Mak-CAD)
REFNo: SIR402ES
1. Advance research and innovations in priority Artificial Intelligence for development (AI4D) areas, which include; AI in Healthcare, AI in Agriculture, Natural Language Processing, and AI for environment and climate challenges.
2. Train MSc and PhDs in thematic AI4D areas
3. Enhance AI4D impact through research translation and collaborations
|
Uganda |
2024-09-27 13:00:42 |
2027-09-27 |
Engineering and Technology |
Non-Clinical Trial |
Non-degree Award |
|
Joel Ogwang
ID: UNCST-2022-R009783
|
Initiating cattle health genomics research and applications in Uganda
REFNo: A462ES
1) Provide insight into the genetic composition and diversity of Ugandan cattle through the sampling and analysis of genotypes across multiple Ugandan farms.
2) Linking the genetic data with health data that are already being collected to pilot the utility of the LUNDA platform to facilitate future research and knowledge exchange in cattle health and productivity genomics.
3) Develop a roadmap for future collaborative research in cattle genomics in Uganda.
|
Uganda |
2024-09-27 12:58:24 |
2027-09-27 |
Agricultural Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Susan Nabadda Ndidde
ID: UNCST-2020-R014331
|
Field performance evaluation of the Point of Care Afinion HaemoglobinA1c test (HbA1c) as a diagnostic tool for Diabetes Mellitus (DM) in people living with HIV/AIDS in Uganda.
REFNo: HS4523ES
To determine the operational characteristics a POC afinion device in HBA1C testing by the users.,To determine the feasibility and acceptability of integrating HbA1c as a diagnostic and monitoring tool for DM among PLHIV and TB/HIV patient.,To determine the accuracy of Afinion Hemoglobin A1c test (HbA1c) POC device in diagnosing and monitoring treatment in DM patients LWHIV Iin Uganda in comparison with Cobas C311 as a gold standard.,To evaluate the field performance of the point of Care Afinion Hemoglobin A1c test (HbA1c) as a diagnostic tool for Diabetes Mellitus (DM) in people living with HIV/AIDS.,
|
Uganda |
2024-09-25 15:02:46 |
2027-09-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
GLORIA GERIA Margaret
ID: UNCST-2024-R002971
|
EXPLORING THE IMPLEMENTATION OF GROUP LEARNING IN PRIMARY SCHOOLS: A CASE OF MITYANA DISTRICT
REFNo: SS3100ES
Research Objectives
1.To identify the strategies employed by teachers in forming groups to facilitate group learning in selected primary schools in Mityana district.
2.To examine the perceptions of teachers regarding the implementation of group learning in primary schools.
3.To investigate the experiences of learners in the context of group learning in selected primary schools in Mityana district.
|
Uganda |
2024-09-25 13:42:18 |
2027-09-25 |
Social Science and Humanities |
Non-Clinical Trial |
Degree Award |
|
Isaac Ssewanyana
ID: UNCST-2020-R014336
|
RightSign® HIV 1.2.O Rapid Test Cassette (Whole Blood/Serum/ Plasma) - Diagnostic sensitivity & diagnostic specificity, specimen equivalence, precision and qualification of usability.
REFNo: HS4998ES
4) To demonstrate the usability of this rapid diagnostic test (RDT) when performed by the intended users. It will be assessed whether the intended users comprehend all key messages from labelling and packaging (i.e. label comprehension study) and whether they can correctly interpret pre-determined test results (i.e. result interpretation study).,3) To estimate the precision (repeatability and reproducibility) of the RightSign® HIV 1.2.O Rapid Test Cassette (Whole Blood/Serum/Plasma) according to WHO TSS-1 Part 1: 1.3.1.,2) To demonstrate the equivalence of serum, plasma (EDTA-K2), venous whole blood (EDTA-K2) and fingerprick whole blood collected from HIV positive patients according to WHO TSS-1 Part 1: 1.1.1.,1) To establish the diagnostic sensitivity and diagnostic specificity of the RightSign® HIV 1.2.O Rapid Test Cassette (Whole Blood/Serum/Plasma) in plasma samples according to the WHO TSS-1 part 2.1.,
|
Uganda |
2024-09-25 13:23:10 |
2027-09-25 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|